Inhye Ahn
Clinical trials sponsored by Inhye Ahn, explained in plain language.
-
New combo aims to control CLL in just one year
Disease control Recruiting nowThis study tests a one-year treatment plan using two drugs, pirtobrutinib and obinutuzumab, for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not had treatment before. The goal is to see if this fixed-duration therapy can control the …
Phase: PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a bispecific antibody wipe out stubborn CLL cells?
Disease control Recruiting nowThis pilot study tests whether the drug mosunetuzumab, given alone or with a BTK inhibitor, can clear minimal residual disease (tiny amounts of leftover cancer) in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). About 40 participants who have a…
Phase: PHASE1, PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC